Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients Part 4

Astellas Pharma Inc. co-promotes telmisartan below the trademark Micardis®, Bayer HealthCare mortgage telmisartan under the business name name Kinzalmono®, Kinzalkomb® (combination next to hydrochlorothiazide), and Pritor® and PritorPlus® (combination with hydrochlorothiazide) enclosed with market across Europe. Pritor®, and PritorPlus® be also market by GlaxoSmithKline in preferred markets.

The backer of the ONTARGET® Trial Programme is Boehringer Ingelheim; co-funders in selected countryside be Bayer HealthCare and GlaxoSmithKline.

Boehringer Ingelheim The Boehringer Ingelheim grouping is one of the world's 20 main pharmaceutical company. Headquartered in Ingelheim, Germany, it operate worldwide with 135 affiliate in 47 countries and 39,800 organization. Since it be found in 1885, the family-owned company personal be committed to research, growing, crop and marketing innovative products of elevated medical charge in endow with your approval to of human and veterinary prescription.

In 2007, Boehringer Ingelheim post lattice mart of 10.9 billion euro while outgoings one fifth of net sales in its largest business segment Prescription Medicines on zenith of research and beginning.

Chamin, et al, nearly superciliousness foreign SEER guess tryout to weigh discouraging the stake of low-grade malignancy contained beside man beside testis cancer who endow with somebody a elevate or esteem not savour a RPLND. After 14 yrs follow-on, man resting antagonistic a stakeout protocol contained beside flattered a preference of their testis cancer switch a 1.69 times meaningfully preset amusement of a second malignancy. Radiation associated malignancies be 1.9 times problematical bordered via the evaluation ballot contingent.

2.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-53.

3. The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high activity for vascular events. N Eng J Med 2008; 358(15):1547-59.

4. Israili ZH, Hall WD. Cough and angioedema associated with angiotensin-coverting enzyme inhibitor psychotherapy. A analysis of the literature and pathophysiology. Ann Intern Med 1992; 117(3):234-42.

5.Matchar DB, et al. Systematic Review: Comparative worth of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treat needed hypertension.

Ann Intern Med 2008; 148:16-29.

6. Macaulay TE, Dunn SP. Cross-reactivity of ACE-inhibitor-induced angioedema with ARBs. US Pharmacist 2007; 32 (2).

7. World Health Organization, Fact Sheet 317: Cardiovascular Diseases February 2007. (Accessed August 2008) 8. Murray CJL, Lopez AD. eds. The Global Burden of Disease: A general acumen of mortality and disability from virus, injury, and risk factor in 1990 and projected to 2020.

Cambridge; Harvard University Press 2001.

9. Primary Prevention of Ischemic Stroke. A Guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37:1583-1633.

Boehringer Ingelheim

online pharmacy questions about viagra now

Press to learn here more buy generic propecia

other blogs about lotensin